Money From Sick People: How PBMs Use AWP, Spread, and Rebates to Inflate Drug Costs (Ep.43)

PBMs promise big “discounts,” but what if those discounts are calculated off inflated prices? In this episode of The Benefit Whisperer, Ralph Weber interviews Antonio Ciaccia (46brooklyn Research / Three Axis Advisors) to decode the drug pricing alphabet soup, AWP, MAC, NADAC, rebates, and GPOs, and explain how incentives inside the pharmacy supply chain can drive costs up while still claiming “savings.” Antonio shares why AWP remains the bedrock of legacy PBM contracting, how generic pricing can become a “Wild West,” and why rebates often amount to “money from sick people,” especially for members in high-deductible plans. Practical, plain-English steps for employers: understand compensation, get your full contract, and demand itemized claims data. 00:00 Unveiling the Pharmacy Benefits World 01:42 Antonio’s Journey into Drug Pricing 04:23 Understanding AWP and Its Implications 09:40 The Illusion of Discounts in Drug Pricing 13:06 The Role of PBMs in Drug Pricing 17:02 Challenges in Changing PBM Contracts 20:42 The Financial Incentives of PBMs 22:54 PBM Dysfunction in the Broader Healthcare Context 25:34 The Role of PBMs in Drug Pricing 27:57 Empowering Employers in Drug Cost Management 32:46 Decoding Drug Pricing Acronyms 36:30 The Impact of GPOs and Rebates on Drug Costs 41:44 Understanding the Burden on Patients and Employers Ralph Weber, The Benefit Whisperer Share with a colleague. Email [email protected] · (832) 924-3330 · fixmybenefitsnow.com · Schedule a free 15 minute consultation